BioCentury
ARTICLE | Company News

Therosteon B.V., TiGenix autoimmune, musculoskeletal news

August 30, 2010 7:00 AM UTC

TiGenix spun out its ChondroBoost screening technology into newco Arcarios B.V. (Rotterdam, Netherlands), which was merged with drug discovery company Therosteon. The newco will focus on developing p...